Human Reproductive Technologies Market to Reach US$27.1 billion by 2019 with Strong Growth in U.S. - Transparency Market Research

The worldwide global human reproductive technologies market presents a CAGR of 2.2% over the forecast period and is estimated to reach a value of US$27.1 billion by 2019.The 125-page market report titled “Human Reproductive Technologies Market - Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 - 2019”, is a detailed study of the human reproductive technology global market.  

The report includes analysis of the global market for devices, treatment systems, and drugs supplied by providers of infertility treatments and contraceptive methods. Human reproductive technologies market includes techniques to control pregnancies. It also includes treatment therapies for infertility through artificial or semi-artificial medical methods. The treatments for infertility can involve males and females. According to the research report, the human reproductive technology market is witnessing a rise in demand due to various factors. The factors impelling the human reproductive technology market include significant increase in infertility worldwide, due to lifestyle changes and hazardous habits such as smoking and alcohol consumption, unwanted pregnancy or delayed pregnancy choices, use of contraceptives and government or NGO-sponsored initiatives for contraception. Other factors include the effects of pollution, stress, and lack of timely access to contraceptive methods and prevalence of obesity worldwide. 

The report divides the market segments for human reproductive technology based on infertility treatments and contraceptive technologies for supporting or monitoring human reproduction. The infertility drugs segment by brand includes Follistim AQ, AndroGel, Levitra/Staxyn, Cialis, Viagra, Testim, and Gonal-f. The global human reproductive technology market is also segmented by the various infertility treatments and procedures available in the market such as: Global IVF Procedures, Zygote Intrafallopian Transfer (ZIFT), Infertility Treatment/Assisted Reproductive Technologies (ART), In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), In Vitro Fertilization (IVF), and Gamete Intrafallopian Transfer (GIFT) and Intrauterine Insemination (IUI). Among these treatments segment, Intrauterine Insemination (IUI) led the market due to the low cost and simplicity of the procedure. 

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1876

The report further discusses contraceptive technology segments in human reproductive technologies. These include sub-segments such as contraceptive drugs, contraceptive pills, injectable contraceptive, topical contraceptives, and contraceptive devices. Contraceptive devices are further subdivided into male and female contraceptive devices. In 2012, the global contraceptive markets reached a value of US$16.0 billion. According to the market report forecast, is expected to progress to a CAGR of 5.5% from 2013 to 2019. The oral contraceptives segment had the highest growth in 2012, and this growth is attributed to rise in awareness among the population and because it is an over-the-counter drug that is easily obtained. The male contraceptive segment had a large market share due to easy availability and lack of side effects. 

Browse the full Human Reproductive Technologies Market (Infertility: Drugs and Procedures & Contraceptives: Drugs and Devices) - Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 - 2019 report at http://www.transparencymarketresearch.com/human-reproductive-technologies-market.html

Among the geographical segments, North America had the largest market share for human reproductive technologies in 2012, and was followed by Europe. North America is expected to lead the market till 2019. Asia Pacific is a fast growing geographical market segment due to high population growth and disposable income.The market research report also provides details about companies involved in the human reproductive technologies market. Among these are Merck KGaA, Church & Dwight, Co. Inc., Ferring International Center S.A., Boston Scientific Corporation, Bayer Healthcare AG, and Teva Pharmaceutical Industries, Ltd.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. 

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contacts

Mr. Nachiket

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/